These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 3932579

  • 21. Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation.
    Murphy M, Loudon R, Kobayashi M, Trinchieri G.
    J Exp Med; 1986 Jul 01; 164(1):263-79. PubMed ID: 3088195
    [Abstract] [Full Text] [Related]

  • 22. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells.
    Bonavida B, Katz J, Hoshino T.
    Cell Immunol; 1986 Oct 01; 102(1):126-35. PubMed ID: 3492275
    [Abstract] [Full Text] [Related]

  • 23. Anti-tumor cytotoxic potential and effect on human bone marrow GM-CFU of human LAK cells generated in response to various cytokines.
    Parhar RS, Ernst P, Sheth KV, al-Sedairy ST.
    Eur Cytokine Netw; 1992 Oct 01; 3(3):299-306. PubMed ID: 1498260
    [Abstract] [Full Text] [Related]

  • 24. Mechanisms involved in NK resistance induced by interferon-gamma.
    Ramirez R, Solana R, Carracedo J, Alonso MC, Peña J.
    Cell Immunol; 1992 Mar 01; 140(1):248-56. PubMed ID: 1739986
    [Abstract] [Full Text] [Related]

  • 25. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM, Ortaldo JR, Shalaby MR, Svedersky LP, Nedwin GE, Bringman TS, Hass PE, Aggarwal BB, Herberman RB, Goeddel DV.
    J Immunol; 1986 Oct 15; 137(8):2592-8. PubMed ID: 3760569
    [Abstract] [Full Text] [Related]

  • 26. Human natural killer cytotoxic factor (NKCF): role of IFN-alpha.
    Steinhauer EH, Doyle AT, Kadish AS.
    J Immunol; 1985 Jul 15; 135(1):294-9. PubMed ID: 3998466
    [Abstract] [Full Text] [Related]

  • 27. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
    Schmidt-Wolf IG, Negrin RS, Kiem HP, Blume KG, Weissman IL.
    J Exp Med; 1991 Jul 01; 174(1):139-49. PubMed ID: 1711560
    [Abstract] [Full Text] [Related]

  • 28. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D, Strife A, Atzpodien J, Clarkson BD.
    Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231
    [Abstract] [Full Text] [Related]

  • 29. YAC-1 variant clones selected for resistance to natural killer cytotoxic factors are also resistant to natural killer cell-mediated cytotoxicity.
    Wright SC, Bonavida B.
    Proc Natl Acad Sci U S A; 1983 Mar 15; 80(6):1688-92. PubMed ID: 6572932
    [Abstract] [Full Text] [Related]

  • 30. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
    Platsoucas CD.
    Scand J Immunol; 1986 Jul 15; 24(1):93-108. PubMed ID: 3088722
    [Abstract] [Full Text] [Related]

  • 31. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
    Lu L, Foa P, Chillemi F, Shen RN, Lin ZH, Carow C, Broxmeyer HE.
    Exp Hematol; 1989 Oct 15; 17(9):935-41. PubMed ID: 2506072
    [Abstract] [Full Text] [Related]

  • 32. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec 15; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 33. Sera from patients with colon, breast and lung cancer induce resistance to lysis mediated by NK cytotoxic factors (NKCF).
    Marubayashi M, Solana R, Ramirez R, Aranda E, Galan F, Peña J.
    Br J Cancer; 1991 Jun 15; 63(6):893-6. PubMed ID: 1906292
    [Abstract] [Full Text] [Related]

  • 34. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.
    Hiserodt JC, Britvan L, Targan SR.
    J Immunol; 1983 Dec 15; 131(6):2705-9. PubMed ID: 6358352
    [Abstract] [Full Text] [Related]

  • 35. Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and interferon in neonates.
    Nair MP, Schwartz SA, Menon M.
    Cell Immunol; 1985 Aug 15; 94(1):159-71. PubMed ID: 3926326
    [Abstract] [Full Text] [Related]

  • 36. Release of natural killer cytotoxic factor (NKCF) from canine natural killer (NK) cells stimulated with cytoplasmic membrane of target cells.
    Nakada Y, Tsukatani Y, Kosaka T, Miyamori M, Kuwabara M, Tanaka S, Koide F.
    J Vet Med Sci; 1995 Feb 15; 57(1):165-7. PubMed ID: 7756413
    [Abstract] [Full Text] [Related]

  • 37. Role of natural killer cytotoxic factors in the mechanism of target-cell killing by natural killer cells.
    Bonavida B, Wright SC.
    J Clin Immunol; 1986 Jan 15; 6(1):1-8. PubMed ID: 3958135
    [Abstract] [Full Text] [Related]

  • 38. Bone marrow cell modulation and inhibition of myelopoiesis by large granular lymphocytes and natural killer cells.
    Nagler A, Greenberg PL.
    Int J Cell Cloning; 1990 May 15; 8(3):171-83. PubMed ID: 2140585
    [Abstract] [Full Text] [Related]

  • 39. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y, Bonavida B, Nio Y, Yoshida O.
    Cancer; 1993 Feb 15; 71(4):1313-21. PubMed ID: 7679609
    [Abstract] [Full Text] [Related]

  • 40. Production of interferon and tumour necrosis factor by cloned human natural cytotoxic lymphocytes and T cells.
    Christmas SE, Meager A, Moore M.
    Clin Exp Immunol; 1987 Aug 15; 69(2):441-50. PubMed ID: 2443292
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.